Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's disease.

Advances in neurology

Volumn 69, Issue , 1996, Pages 541-544

  Zoldan, J ^a   Friedberg, G ^a   Weizman, A ^a   Melamed, E ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; LEVODOPA; ONDANSETRON; SEROTONIN ANTAGONIST;

AGED; ARTICLE; CLINICAL TRIAL; DELUSION; FEMALE; HALLUCINATION; HUMAN; MALE; MIDDLE AGED; PARKINSON DISEASE; PSYCHOLOGICAL ASPECT;

AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; DELUSIONS; FEMALE; HALLUCINATIONS; HUMANS; LEVODOPA; MALE; MIDDLE AGED; ONDANSETRON; PARKINSON DISEASE; SEROTONIN ANTAGONISTS;

EID: 0029685890     PISSN: 00913952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)